Silverback Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Silverback Therapeutics generated cash of -$59,266,000, which is less than the previous year. Cash used in financing activities reached the amount of $6,899,000 last year. Net change in cash is therefore -$139,547,000.
Cash Flow
| 2018 | -16.87M | -449K | 19.39M |
|---|---|---|---|
| 2019 | -18.89M | -96K | 8.61M |
| 2020 | -31.19M | -917K | 408.50M |
| 2021 | -66.76M | -66.47M | 614K |
| 2022 | -40.07M | -199K | 190.73M |
| 2023 | -59.26M | -87.18M | 6.89M |
SBTX Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 210.51M | 60.06M | 386.91M | 10.52M | 20.91M | 18.83M |
Operating activities | ||||||
Net income | -54.36M | -34.68M | -89.47M | -32.94M | -23.96M | -17.57M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 73K | 319K | 783K | 637K | 544K | 480K |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -2.77M | -10.28M | 6.03M | 1.79M | 0 | 0 |
Cash generated by operating activities | -59.26M | -40.07M | -66.76M | -31.19M | -18.89M | -16.87M |
Investing activities | ||||||
Purchases Of Investments | -272.00M | 0 | -65.10M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -175K | -199K | -1.37M | -917K | -96K | -449K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -87.18M | -199K | -66.47M | -917K | -96K | -449K |
Financing activities | ||||||
Common Stock Issued | 0 | 570K | 1.46M | 258.28M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 1.46M | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -846K | -700K | 0 | -852K |
Cash used in financing activities | 6.89M | 190.73M | 614K | 408.50M | 8.61M | 19.39M |
Net Change In Cash | -139.54M | 150.45M | -132.62M | 376.39M | -10.38M | 2.07M |
Cash at end of period | 70.97M | 210.51M | 254.29M | 386.91M | 10.52M | 20.91M |
| Data source | Data source | Data source | Data source |